Development of liquid chromatography/mass spectrometry, methods for the quantitative analysis of herbal medicine in biological fluids: a review

被引:41
作者
Gray, Michael J. [1 ]
Chang, Dennis [1 ]
Zhang, Ying [2 ]
Liu, Jianxun [2 ]
Bensoussan, Alan [1 ]
机构
[1] Univ Western Sydney, Ctr Complementary Med Res, Penrith, NSW 1797, Australia
[2] China Acad Chinese Med Sci, Xi Yuan Hosp, Beijing, Peoples R China
关键词
liquid chromatography-mass spectrometry; Ginkgo biloba; Panax ginseng; bioactive compounds; herbal medicine; biological fluids; IONIZATION-MASS-SPECTROMETRY; PRESSURE CHEMICAL-IONIZATION; SOLID-PHASE EXTRACTION; GINKGO-BILOBA EXTRACT; TRADITIONAL CHINESE MEDICINE; TOTAL PANAX NOTOGINSENOSIDE; LABELED INTERNAL STANDARDS; ELECTROSPRAY-IONIZATION; RAT PLASMA; TERPENE LACTONES;
D O I
10.1002/bmc.1287
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
The development of liquid chromatography-mass spectrometry [LC-MS) and tandem MS/MS for the analysis of bioactive components and their metabolites of herbal medicines in biological fluids is reviewed with the aim of providing an overview of the current techniques and methods used. The issues and challenges associated with various stages of the analytical method development are discussed using Ginkgo biloba and Panax ginseng as case studies. LC-MS offers selectivity and specificity in both the chromatographic separation and detection steps. This is necessary in order to measure compounds at extremely low concentrations as is often observed in plasma and urine samples. Traditional methods of detection (UV-visible) do not offer sufficient selectivity and specificity needed. The strategies and pitfalls involved with the measurement of such compounds are discussed in this review. Matrix effects, 'unseen' matrix suppression and enhancement ionization effects can significantly reduce the accuracy and precision of the measurement. The impact of the correct choice of chromatography column formats on signal-to-noise ratio is also discussed. Analytical methods from sample preparation to mass spectrometric detection is outlined in order to provide good direction for analysts intent on the measurement of bioavailable compounds from herbal medicines in plasma and urine samples. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:91 / 103
页数:13
相关论文
共 73 条
[1]
Agilent Technologies, 2007, ION OPT INN INCR SEN, P1
[2]
[Anonymous], 2001, GUIDANCE IND, P1
[3]
The ion suppression phenomenon in liquid chromatography-mass spectrometry and its consequences in the field of residue [J].
Antignac, JP ;
de Wasch, K ;
Monteau, F ;
De Brabander, H ;
Andre, F ;
Le Bizec, B .
ANALYTICA CHIMICA ACTA, 2005, 529 (1-2) :129-136
[4]
*APPL BIOS, 2006, API 4000 LC MS MS SY
[5]
Scanning the controls: Genomics and nanotechnology [J].
Austin, RH ;
Tegenfeldt, JO ;
Cao, H ;
Chou, SY ;
Cox, EC .
IEEE TRANSACTIONS ON NANOTECHNOLOGY, 2002, 1 (01) :12-18
[6]
Quantitative characterization of differential ion suppression on liquid chromatography/atmospheric pressure ionization mass spectrometric bioanalytical methods [J].
Avery, MJ .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2003, 17 (03) :197-201
[7]
Bioavailability of ginkgolides and bilobalide from extracts of Ginkgo biloba using GC/MS [J].
Biber, A ;
Koch, E .
PLANTA MEDICA, 1999, 65 (02) :192-193
[8]
THERMOSPRAY INTERFACE FOR LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
BLAKLEY, CR ;
VESTAL, ML .
ANALYTICAL CHEMISTRY, 1983, 55 (04) :750-754
[9]
Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO
[10]
2-0